Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure:: Role of changes in thymic output and T cell death

被引:63
|
作者
Lecossier, D
Bouchonnet, F
Schneider, P
Clavel, F
Hance, AJ
机构
[1] Hop Bichat Claude Bernard, INSERM, U552, IMEA, F-75018 Paris, France
[2] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland
来源
JOURNAL OF INFECTIOUS DISEASES | 2001年 / 183卷 / 07期
关键词
D O I
10.1086/319285
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Some patients infected with human immunodeficiency virus (HIV) who are experiencing antiretroviral treatment failure have persistent improvement in CD4(+) T cell counts despite high plasma viremia. To explore the mechanisms responsible for this phenomenon, 2 parameters influencing the dynamics of CD4(+) T cells were evaluated: death of mature CD4(+) T cells and replenishment of the CD4(+) T cell pool by the thymus. The improvement in CD4(+) T cells observed in patients with treatment failure was not correlated with spontaneous, Fas ligand-induced, or activation-induced T cell death. In contrast, a significant correlation between the improvement in CD4(+) T cell counts and thymic output, as assessed by measurement of T cell receptor excision circles, was observed. These observations suggest that increased thymic output contributes to the dissociation between CD4(+) T cell counts and viremia in patients failing antiretroviral therapy and support a model in which drug-resistant HIV strains may have reduced replication rates and pathogenicity in the thymus.
引用
收藏
页码:1009 / 1016
页数:8
相关论文
共 50 条
  • [41] In Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells
    Nemeth, Johannes
    Vongrad, Valentina
    Metzner, Karin J.
    Strouvelle, Victoria P.
    Weber, Rainer
    Pedrioli, Patrick
    Aebersold, Ruedi
    Gunthard, Huldrych F.
    Collins, Ben C.
    MOLECULAR & CELLULAR PROTEOMICS, 2017, 16 (04) : S108 - S123
  • [42] TARGETING OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS BY CD8(+) T-LYMPHOCYTES ARMED WITH UNIVERSAL T-CELL RECEPTORS
    ROBERTS, MR
    QIN, L
    ZHANG, DZ
    SMITH, DH
    TRAN, AC
    DULL, TJ
    GROOPMAN, JE
    CAPON, DJ
    BYRN, RA
    FINER, MH
    BLOOD, 1994, 84 (09) : 2878 - 2889
  • [43] Evidence for Altered Glutamine Metabolism in Human Immunodeficiency Virus Type 1 Infected Primary Human CD4+ T Cells
    Hegedus, Andrea
    Williamson, Maia Kavanagh
    Khan, Mariam B.
    Zeidler, Julianna Dias
    Da Poian, Andrea T.
    El-Bacha, Tatiana
    Struys, Eduard A.
    Huthoff, Hendrik
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (12) : 1236 - 1247
  • [44] Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection
    Blankson, JN
    Finzi, D
    Pierson, TC
    Sabundayo, BP
    Chadwick, K
    Margolick, JB
    Quinn, TC
    Siliciano, RF
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06): : 1636 - 1642
  • [45] Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients
    Woffendin, C
    Ranga, U
    Yang, ZY
    Xu, L
    Nabel, GJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) : 2889 - 2894
  • [46] Understanding the basis of CD4+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus
    Etemad-Moghadam, B
    Rhone, D
    Steenbeke, T
    Sun, Y
    Manola, J
    Gelman, R
    Fanton, JW
    Racz, P
    Tenner-Racz, K
    Axthelm, MK
    Letvin, NNL
    Sodroski, J
    VACCINE, 2002, 20 (15) : 1934 - 1937
  • [47] Alterations in T-cell receptor Vβ repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children
    Kharbanda, M
    McCloskey, TW
    Pahwa, R
    Sun, M
    Pahwa, S
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (01) : 53 - 58
  • [48] The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques
    Karlsson, GB
    Halloran, M
    Schenten, D
    Lee, J
    Racz, P
    Tenner-Racz, K
    Manola, J
    Gelman, R
    Etemad-Moghadam, B
    Desjardins, E
    Wyatt, R
    Gerard, NP
    Marcon, L
    Margolin, D
    Fanton, J
    Axthelm, MK
    Letvin, NL
    Sodroski, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06): : 1159 - 1171
  • [49] Cutaneous adverse reactions and CD4+ cell counts in human immunodeficiency virus-infected patients receiving trimethoprim-sulfamethoxazole
    Caumes, E
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) : 530 - 531
  • [50] CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy
    Deeks, SG
    Hoh, R
    Grant, RM
    Wrin, T
    Barbour, JD
    Narvaez, A
    Cesar, D
    Abe, K
    Hanley, MB
    Hellmann, NS
    Petropoulos, CJ
    McCune, JM
    Hellerstein, MK
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (03): : 315 - 323